J&J Unit Settles Off-Label Marketing Claims For $81M
A unit of Johnson & Johnson has agreed to pay more than $81 million to put to rest a U.S. Department of Justice inquiry into off-label marketing of the epilepsy and...To view the full article, register now.
Already a subscriber? Click here to view full article